A Quote by Mina Kimes

One of the most watched - and least meaningful - financial metrics each quarter is the number of 'earnings surprises,' or instances in which companies' profits beat analysts' expectations.
Trust-me companies are companies whose financial results gallop ahead of their businesses, companies with seemingly perfect control over their quarterly sales and profits. Companies whose financial statements are loaded with footnotes: companies that short-sellers often attack but rarely dent.
The biggest profit center for investment banks is the hefty fees they charge for underwriting stock offerings and giving financial advice, and analysts put those profits at risk if they publish negative conclusions about the companies that pay the fees.
The danger of tautological propositions is considerable in discussions of the concept of normal profits. Because supernormal profits seem to invite newcomers to an industry and sub-normal profits seem to drive away those who are in an industry, some writers are inclined to define normal profits as the earnings of the fixed resources in an industry which neither grows nor declines in size or number of firms. It should be clear that such a definition is useless: it muddles together attractiveness and actual afflux, desirbility of entry and ease of entry, zero profits and monopoly rents.
A young financial writer once brought ridicule upon himself by stating that a certain company had nothing to commend it except excellent earnings. Well, there are companies whose earnings are excellent but whose stocks I would never recommend. In selecting investments, I attach prime importance to the men behind them. I'd rather buy brains and character than earnings. Earnings can be good one year and poor the next. But if you put your money into securities run by men combining conspicuous brains and unimpeachable character, the likelihood is that the financial results will prove satisfactory.
While many have been left behind by Part D, there is a clear winner: the drug industry. Independent analysts predict that Part D will increase drug industry profits by $139 billion over the next eight years. Glaxo-SmithKline's second-quarter net income already jumped 14 percent, and other leading drug companies also have benefited.
Of course if you are launching a new business you can thinking about revenues, profits, and so on, but metrics such as customer satisfaction or employee retention might be meaningful if you are focusing more internally.
The list of companies that have added their own financial metrics is not a savory group.
The global financial crisis - missed by most analysts - shows that most forecasters are poor at pricing in economic/financial risks, let alone geopolitical ones.
We met financial expectations for the quarter in a difficult economic environment. We also signed a two-year programming agreement with Home & Garden Television to launch two new cable television series, and launched the Martha Stewart Kids magazine These initiatives provide future revenue and earnings growth for the brand and build long-term value for shareholders.
Too many companies these days can't tell the difference between good profits and bad.... By now you're probably wondering how in heaven's name profit, that holy grail of the business enterprise, can ever be bad. Short of outright fraud, isn't one dollar of earnings as good as another? Certainly, accountants can't tell the difference between good and bad profits. They all look the same on an income statement. While bad profits don't show up on the books, they are easy to recognize. They're profits earned at the expense of customer relationships.
Over 10 years, MindTree has been ahead of most IT companies on operating and financial metrics. We have stayed true to our long-term vision and have not been buffeted by short-term.
We have full disclosure in transparency of our audited, our financial audits. It's on our Web site. It is, I think 16 or 20- something pages, which most public companies or private companies and most ministries don't disclose. So we have always operated with financial integrity and full transparency.
The All-Wise Maker attaches hundreds of instances of wisdom to each of the beings in the palace of the universe and equips them to perform hundreds of duties. To all trees He bestows instances of wisdom to the number of its fruits and gives duties to the number of its flowers.
Publicly traded United States companies report sales and profits to investors every quarter.
It's one of the fundamental principles of the stock market: When interest rates go up, stocks go down. And along with financial companies and cyclicals, technology companies - with their sky-high price-to-earnings multiples - should be among the biggest losers in an environment of rising rates.
Philosophy is antipoetic. Philosophize about mankind and you brush aside individual uniqueness, which a poet cannot do without self-damage. Unless, for a start, he has a strong personal rhythm to vary his metrics, he is nothing. Poets mistrust philosophy. They know that once the heads are counted, each owner of a head loses his personal identify and becomes a number in some government scheme: if not as a slave or serf, at least as a party to the device of majority voting, which smothers personal views.
This site uses cookies to ensure you get the best experience. More info...
Got it!